Cleared Traditional

K230375 - BIOMONITOR IV (FDA 510(k) Clearance)

May 2023
Decision
95d
Days
Class 2
Risk

K230375 is an FDA 510(k) clearance for the BIOMONITOR IV. This device is classified as a Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) (Class II - Special Controls, product code MXD).

Submitted by Biotronik, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on May 19, 2023, 95 days after receiving the submission on February 13, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1025.

Submission Details

510(k) Number K230375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2023
Decision Date May 19, 2023
Days to Decision 95 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MXD — Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1025

Similar Devices — MXD Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)

All 14
Assert-IQ (DM5100)
K253516 · Abbott Medical · Dec 2025
LUX-Dx II Insertable Cardiac Monitor (M302)
K252593 · Boston Scientific Corporation · Sep 2025
LINQ II™ Insertable Cardiac Monitor (ICM)
K240693 · Medtronic, Inc. · Mar 2024
LINQ II Insertable Cardiac Monitor
K233562 · Medtronic, Inc. · Dec 2023
LINQ II™ Insertable Cardiac Monitor (LNQ22)
K233320 · Medtronic, Inc. · Oct 2023
LUX-Dx II (M302)
K231328 · Boston Scientific Corp · Aug 2023